PDL BioPharma Buys Novartis Hypertension Drugs

PDL BioPharma commits to equity investment in Noden Pharma for the acquisition of Tekturna and Tekturna HCT
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news